Cite
Donor-Derived Cell-Free DNA as a Potential Biomarker for Acute Cellular Rejection Surveillance (FreeDNA-CAR Study).
MLA
Jimenez-Blanco Bravo, M., et al. “Donor-Derived Cell-Free DNA as a Potential Biomarker for Acute Cellular Rejection Surveillance (FreeDNA-CAR Study).” Journal of Heart & Lung Transplantation, vol. 42, Apr. 2023, pp. S433–34. EBSCOhost, https://doi.org/10.1016/j.healun.2023.02.1217.
APA
Jimenez-Blanco Bravo, M., Crespo-Leiro, M., Garcia-Cosio, M., Perez-Gomez, L., Lopez-Vilella, R., Ortiz Bautista, C., Farrero Torres, M., Maestro Benedicto, A., Diaz Molina, B., Diez-Lopez, C., Rangel Sousa, D., Salterain, N., Garrido Bravo, I., & Segovia-Cubero, J. (2023). Donor-Derived Cell-Free DNA as a Potential Biomarker for Acute Cellular Rejection Surveillance (FreeDNA-CAR Study). Journal of Heart & Lung Transplantation, 42, S433–S434. https://doi.org/10.1016/j.healun.2023.02.1217
Chicago
Jimenez-Blanco Bravo, M., M. Crespo-Leiro, M. Garcia-Cosio, L. Perez-Gomez, R. Lopez-Vilella, C. Ortiz Bautista, M. Farrero Torres, et al. 2023. “Donor-Derived Cell-Free DNA as a Potential Biomarker for Acute Cellular Rejection Surveillance (FreeDNA-CAR Study).” Journal of Heart & Lung Transplantation 42 (April): S433–34. doi:10.1016/j.healun.2023.02.1217.